Cardlytics (CDLX) Capital Expenditures (2017 - 2026)

Cardlytics has reported Capital Expenditures for 10 years, with the latest figure at $28000.0 in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 76.47% year-over-year to $28000.0; the trailing twelve-month figure through Mar 2026 stood at $15.2 million (down 11.58% YoY), and the FY2025 full-year result was $15.3 million, down 13.72% from the prior year.
• Capital Expenditures for Q1 2026 stood at $28000.0, down from $15.2 million in the prior quarter.
• The five-year high for Capital Expenditures was $16.3 million in Q4 2024, with the low at -$8.0 million in Q4 2022.
• Historically, Capital Expenditures has averaged $2.2 million across 5 years, with a median of $659000.0 in 2023.
• The largest YoY upside for Capital Expenditures was 2933.83% in 2022 against a maximum downside of 435.25% in 2022.
• Cardlytics' Capital Expenditures stood at -$8.0 million in 2022, then soared by 108.34% to $667000.0 in 2023, then soared by 2343.33% to $16.3 million in 2024, then retreated by 6.97% to $15.2 million in 2025, then sank by 99.82% to $28000.0 in 2026.
• The last three Capital Expenditures figures came in at $28000.0 (Q1 2026), $15.2 million (Q4 2025), and -$300000.0 (Q3 2025), per Business Quant data.